Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

HealthStream, Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Healthcare Information ServicesSector: Healthcare

Fair Value Summary

Current Price$24.37
5Y Range42.85 – 63.52
5Y Selected53.19
(-) Safety Margin68.16%
5Y Buy Price$16.93
Upside (to Buy Price)-30.51%
10Y Range45.90 – 66.31
10Y Selected56.10
(-) Safety Margin68.16%
10Y Buy Price$17.86
Upside (to Buy Price)-26.70%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9987
Revenue R2 (10Y)0.8912
Net Income R2 (5Y)0.4232
Net Income R2 (10Y)0.0646
EBITDA R2 (5Y)0.9068
EBITDA R2 (10Y)0.9536
FCF R2 (5Y)0.0293
FCF R2 (10Y)0.5123
Safety Score0.3184

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth4.14%4.13%4.11%4.09%4.08%4.06%4.05%4.03%4.02%4.00%
Revenue303.72316.25329.25342.73356.70371.19386.22401.79417.92434.64
EBITDA113.67118.36123.22128.27133.50138.92144.55150.37156.41162.67
D&A-42.78-44.55-46.38-48.28-50.24-52.29-54.40-56.59-58.87-61.22
EBIT70.8973.8176.8579.9983.2686.6490.1593.7897.55101.45
Pro forma Taxes-15.34-15.97-16.62-17.31-18.01-18.74-19.50-20.29-21.10-21.95
NOPAT55.5557.8560.2262.6965.2567.9070.6473.4976.4479.50
Capital Expenditures-15.26-15.89-16.54-17.22-17.92-18.65-19.41-20.19-21.00-21.84
NWC Investment2.552.642.742.842.953.063.173.283.403.53
(+) D&A42.7844.5546.3848.2850.2452.2954.4056.5958.8761.22
Free Cash Flow85.6289.1492.8096.59100.51104.59108.81113.18117.71122.41
Diluted Shares Outstanding30,371,750.0030,371,750.0030,371,750.0030,371,750.0030,371,750.0030,371,750.0030,371,750.0030,371,750.0030,371,750.0030,371,750.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.45%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF84.8885.6481.7277.9674.3770.9367.6464.4961.4858.60
Raw: 1,547.89
1,096.44
Raw: 1,885.06
863.95

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value1,501.021,591.64
(-) Net Debt-43.60-43.60
Equity Value1,544.621,635.25
(/) Shares Out30.3730.37
Fair Value$50.86$53.84
(-) Safety Margin68.16%68.16%
Buy Price$16.19$17.14
Current Price$24.37$24.37
Upside (to Buy Price)-33.55%-29.66%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.95%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF84.8085.2980.6476.2372.0668.1064.3560.8057.4354.24
Raw: 1,256.92
858.74
Raw: 1,530.71
646.47

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value1,257.751,350.40
(-) Net Debt-43.60-43.60
Equity Value1,301.361,394.01
(/) Shares Out30.3730.37
Fair Value$42.85$45.90
(-) Safety Margin68.16%68.16%
Buy Price$13.64$14.61
Current Price$24.37$24.37
Upside (to Buy Price)-44.02%-40.03%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.95%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF84.9686.0182.8279.7576.7773.9071.1268.4465.8563.35
Raw: 2,008.28
1,475.39
Raw: 2,445.73
1,217.31

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value1,885.701,970.28
(-) Net Debt-43.60-43.60
Equity Value1,929.302,013.89
(/) Shares Out30.3730.37
Fair Value$63.52$66.31
(-) Safety Margin68.16%68.16%
Buy Price$20.23$21.11
Current Price$24.37$24.37
Upside (to Buy Price)-17.01%-13.37%

Reverse DCF: Market Implied Growth

Current Price$24.37
WACC Used9.1%
IMPLIED REVENUE GROWTH125.85%
Metric2027202820292030203120322033203420352036
Implied Revenue674.381,523.123,440.027,769.4517,547.6539,632.1589,511.00202,164.61456,597.841,031,246.74
Constant Implied Growth125.85%125.85%125.85%125.85%125.85%125.85%125.85%125.85%125.85%125.85%
Implied Free Cash Flow0.070.150.340.781.753.968.9520.2245.66103.12
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF0.060.120.250.531.092.264.679.6820.0341.48

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$27.205.65%$29.076.89%
20182018-12-31$24.154.30%$18.12-24.97%
20172017-12-31$23.164.22%$19.04-17.77%
20162016-12-31$25.051.57%$6.36-74.62%
20152015-12-31$22.001.55%$13.21-39.94%
20142014-12-31$29.482.50%$17.63-40.20%
20132013-12-31$32.634.07%$13.99-57.14%
20122012-12-31$24.3110.53%$14.02-42.31%
20112011-12-31$18.4515.14%$15.58-15.56%
20102010-12-31$8.0417.30%$17.14113.24%
20092009-12-31$3.9517.33%$12.87225.79%
20082008-12-31$2.3314.94%$5.23124.61%
20072007-12-31$3.5013.38%$4.0315.10%
20062006-12-31$3.9514.48%$0.90-77.25%
20052005-12-31$2.3317.28%$6.77190.48%
20042004-12-31$2.6819.22%$-1.92-171.56%
20032003-12-31$2.6022.14%$-2.57-198.99%
20022002-12-31$1.4120.25%$-10.89-872.26%
20012001-12-31$1.1016.49%$-16.81-1,628.42%
20002000-12-31$1.0015.25%$-30.81-3,180.66%
19991999-12-31$8.5012.07%$-28.29-432.83%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$55.22
Median
$53.64
10th Percentile
$45.52
90th Percentile
$67.17

Fair Value Distribution

$38.59 - $41.56
11
$41.56 - $44.52
59
$44.52 - $47.49
114
$47.49 - $50.45
148
$50.45 - $53.41
160
$53.41 - $56.38
128
$56.38 - $59.34
106
$59.34 - $62.31
85
$62.31 - $65.27
64
$65.27 - $68.23
41
$68.23 - $71.20
30
$71.20 - $74.16
14
$74.16 - $77.13
13
$77.13 - $80.09
12
$80.09 - $83.05
5
$83.05 - $86.02
5
$86.02 - $88.98
3
$88.98 - $91.95
1
$91.95 - $94.91
0
$94.91 - $97.87
1